Jeffers M D, O'Dowd G M, Mulcahy H, Stagg M, O'Donoghue D P, Toner M
Department of Pathology, St James's Hospital, Dublin, Ireland.
J Pathol. 1994 Feb;172(2):183-7. doi: 10.1002/path.1711720205.
Micrometastases have been detected by immunocytochemical means in the lymph nodes of patients with otherwise node-negative cancer of the colon and rectum. This study examines the incidence and prognostic significance of nodal micrometastases in Dukes' B carcinoma. Five hundred and fifty-nine lymph nodes from 77 cases of Dukes' B carcinoma were examined for lymph node micrometastases by immunocytochemical staining for cytokeratin AE1:AE3. Micrometastases were detected in 19 cases (25 per cent). Cell clusters were present in ten cases, the remaining nine cases displaying only single cells. The presence of micrometastases was unrelated to age (P = 0.06), sex (P = 0.32), tumour site (P = 0.37), tumour size (P = 0.67), or tumour differentiation (P = 0.66). Ten-year survival estimates by the Kaplan-Meier lifetable method was 47 per cent in patients with and without micrometastases (chi 2 = 0.35 and 1 df, P = ns). The presence of nodal micrometastases detectable only by immunocytochemistry in patients with Dukes' B colorectal cancer does not justify reassignment to a more advanced disease stage.
通过免疫细胞化学方法已在患有其他方面为淋巴结阴性的结肠直肠癌患者的淋巴结中检测到微转移。本研究探讨了Dukes B期癌中淋巴结微转移的发生率及其预后意义。对77例Dukes B期癌患者的559个淋巴结进行免疫细胞化学染色检测细胞角蛋白AE1:AE3,以检查淋巴结微转移情况。在19例(25%)患者中检测到微转移。10例出现细胞簇,其余9例仅显示单个细胞。微转移的存在与年龄(P = 0.06)、性别(P = 0.32)、肿瘤部位(P = 0.37)、肿瘤大小(P = 0.67)或肿瘤分化程度(P = 0.66)无关。采用Kaplan-Meier生存表法估计,有和无微转移患者的10年生存率均为47%(χ2 = 0.35,自由度为1,P = 无显著性差异)。在Dukes B期结直肠癌患者中,仅通过免疫细胞化学检测到的淋巴结微转移并不足以将其重新归类为更晚期的疾病阶段。